Chinese Journal of Hepatology 2005 Issue 2 Subgenomic replicon model of hepatitis C virus and it's application

Subgenomic replicon model of hepatitis C virus and it's application
jia yin tang ; wei lai

..............page:158-160

A report of acute hepatitis E with immunologic hemolysis
jin shu qing ; chen xiang rong ; wu xiao li ; han qing xi

..............page:120

Apoptosis of rat hepatic stellate cells induced by Panax notoginseng saponins
wang wen bing ; dai li li ; zheng yuan yi

..............page:156-157

Effect of hepatocyte cytochrome P450 2E1 gene and its expression in nonalcoholic steatosis in rats
shi hong tao ; chen dong feng ; li tao ; xiong ren ping

..............page:154-155

Expression of subtypes of somatostatin receptors in rat hepatic stellate cells
song sheng zuo ; leng xi sheng ; li tao ; peng ji run ; qin zhi zhong ; zhao li ; wei yu hua ; yu zuo

..............page:152-153

Effect of Angiotensin Ⅱ on NF-kappa B activity and expression of PDGF-BB, TGF beta 1 and COX-2 in Kupffer's cells
li xu ; meng ying ; chen zuo ; yang xi shan ; zhou gao su ; wu ping sheng

..............page:150-151

HCV core protein effects on the expression of mutation p53 and Bcl-2 protein in HCV hepatitis and cirrhosis
wang wen yong ; zhang zhi pei ; huang li jun ; ma fu cheng ; zhao yi ling

..............page:148-149

Expression and significance of erb-B receptor family in hepatocellular carcinoma
cao zuo ; zhao yin nong ; wu fei xiang ; ou chao ; ban ke chen ; wei zuo ; li zuo ; su jian jia ; liang an min

..............page:146-147

Pexoxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats
guo zuo tong ; leng xi sheng ; zhao jing ming ; zuo xi hou ; li tao ; zhu ji ye

..............page:145-146

Treatment of nonalcoholic fatty liver disease: behavior modification, diet therapy and exercise programs
lu lun gen ; zeng min de

..............page:138

Current therapeutic strategy of fatty liver diseases
fan jian gao

..............page:136-137

Molecular mechanisms of the protection of SNMC in HepG2 cell apopotosis
wang yan ; ma ying zuo ; yang bao shan ; bi man ru ; chen li yan

..............page:132-135

A discussion of standardization for prothrombin time in patients with advanced liver diseases
li qin ; cong yu long ; wang bao en ; jia ji dong ; chen zuo ; zhang fu kui ; ou xiao juan ; wei yu xiang ; ma hong

..............page:128-131

Effect of tea polyphenols on alcoholic liver injury
zhang yu ; chen shao hua ; zhang xing guo ; ren guo ping ; sa xiao ying ; yu chao hui ; li you ming

..............page:125-127

Preparation and identification of hammerhead ribozyme in vitro against caspase-12 mRNA fragments
jiang shan ; xie qing ; zhang ( wei hua ); zhou xia qiu ; yu hong ; jin you xin

..............page:121-124

Evaluation of the value of ultrasonography in diagnosis of liver fibrosis in patients with chronic viral hepatitis
shen lei ; li ji qiang ; zeng min de ; fan si tao ; lu lun gen ; bao zuo ; cao ai ping

..............page:117-120

Effects of portaazygous disconnection, portocaval shunt and selective shunts on experimental rat liver cirrhosis
xu xin bao ; cai jing xiu ; dong jia hong ; he zhen ping ; han ben li ; leng xi sheng

..............page:113-116

Distribution of hepatitis B virus genotypes in Hubei province and its clinical significance
lei yan chang ; hao you hua ; tian yong jun ; meng zhong ji ; wang bao ju ; tian de ying ; zhao xi ping ; yang dong liang

..............page:109-112

Establishing a rat insulin-resistant fatty liver model
chen shi qing ; liu zuo ; sun hang ; zhang gui ling ; shi xiao feng

..............page:105-108

Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding
gao zhi qiang ; lu fu er ; dong hui ; xu li jun ; wang kai fu ; zou xin

..............page:101-104

Relationship between NF-kappa B binding activity and expression of PPAR gamma-mRNA in the livers of rats with fatty liver disease
zhao cai yan ; wang jian bin ; deng zhuo jun ; liu jing wen ; li jian mei ; li li ; jiang ling ling

..............page:96-100

Diisopropylamine dichloroacetate in the treatment of nonalcoholic fatty liver disease: a multicenter random double-blind controlled trial
lu lun gen ; zeng min de ; mao yi min ; chen cheng wei ; fu qing chun ; wang ji yao ; xie wei fen ; fan jian gao ; chen dong feng ; wang bing yuan

..............page:92-95

Effect of Endotoxin on the expression of peroxisome proliferator-activated receptor alpha in the development of nonalcoholic steatohepatitis in rats
li xia ; han de wu ; zhao long feng ; yin lei

..............page:89-91

Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai
fan jian gao ; zhu jun ; li xin jian ; li rui ; dai fei ; song xiao min ; chen lan ; li feng ; chen shi yao

..............page:83-88

Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease
zeng min de

..............page:81-82

The application of Bletilla striata in the interventional therapy of hepatocellular carcinoma: a comparative study using ACI rats
qian jun ; zheng chuan sheng ; wu han ping ; li wei yong ;vossoughi daryusch;elsie oppermann;thomas vogl; feng gan sheng

..............page:143-144

The level of serum thrombopoietin in patients with chronic hepatic diseases suffering from thrombocytopenia
xie yu tao ; jiang xiao hua ; tan de ming

..............page:142-143

Comparision of the serotypes and genotypes of hepatitis B virus among HBsAg positive hepatitis B patients in a northern city and a southern city of China
lv zhi wu ; xu jun ; yin ji mei ; xu wei

..............page:95,100

Evaluation of treatments for nonalcoholic fatty liver disease
li you ming

..............page:141

Abstinence and fatty liver
wang bing yuan

..............page:140

Drug therapy for nonalcoholic fatty liver disease
shen zuo

..............page:139